Time Since Last Anti-CD20 Treatment Is a Major Determinant of Sars-Cov-2 Vaccine Response in a Large Cohort of Patients with B-Cell Lymphoma

被引：0
|
作者：
Shree, Tanaya [1 ]
Shankar, Vishnu [1 ]
Czerwinski, Debra K. [2 ]
Rodriguez, Gladys [1 ]
Beygi, Sara [3 ,4 ]
Schroers-Martin, Joseph G. [5 ,6 ]
Advani, Ranjana [7 ]
Maeda, Lauren S. [2 ,8 ]
Gupta, Neel K. [2 ,8 ]
Khodadoust, Michael S. [1 ,9 ]
Kurtz, David M. [1 ]
Corbelli, Karen S. [10 ]
Gabriel, Etelka [1 ]
Kanegai, Alyssa M. [1 ]
Alizadeh, Ash A. [11 ,12 ]
Levy, Ronald [1 ]
机构：
[1] Stanford Univ, Dept Med, Div Oncol, Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Med Ctr, Div Oncol, Dept Med, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, Div Oncol, Stanford, CA 94305 USA
[5] Stanford Univ, Div Hematol, Dept Med, Stanford, CA USA
[6] Stanford Univ, Div Oncol, Dept Med, Stanford, CA USA
[7] Stanford Canc Inst, Lymphoma, Dept Med, Div Oncol, Stanford, CA USA
[8] Stanford Univ, Med Ctr, Div Hematol, Dept Med, Stanford, CA 94305 USA
[9] Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94305 USA
[10] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[11] Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA
[12] Stanford Univ, Dept Med, Div Hematol, Stanford, CA 94305 USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-153901
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2064
引用
收藏
页数：6
相关论文
共 50 条
  • [31] Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20
    Weiskopf, Kipp
    Anderson, Katie L.
    Ito, Daisuke
    Schnorr, Peter J.
    Tomiyasu, Hirotaka
    Ring, Aaron M.
    Bloink, Kristin
    Efe, Jem
    Rue, Sarah
    Lowery, David
    Barkal, Amira
    Prohaska, Susan
    McKenna, Kelly M.
    Cornax, Ingrid
    O'Brien, Timothy D.
    O'Sullivan, M. Gerard
    Weissman, Irving L.
    Modiano, Jaime F.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (12) : 1072 - 1087
  • [32] Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy
    Czuczman, MS
    Grillo-López, AJ
    White, CA
    Saleh, M
    Gordon, L
    LoBuglio, AF
    Jonas, C
    Klippenstein, D
    Dallaire, B
    Varns, C
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 268 - 276
  • [33] EConvalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literature
    Oliva, Alessandra
    Cancelli, Francesca
    Brogi, Andrea
    Curtolo, Ambrogio
    Savelloni, Giulia
    Siccardi, Guido
    Marcelli, Giulia
    Mazzuti, Laura
    Ricci, Paolo
    Turriziani, Ombretta
    Antonelli, Guido
    Venditti, Mario
    Mastroianni, Claudio M.
    NEW MICROBIOLOGICA, 2022, 45 (01): : 62 - 72
  • [34] Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosis
    Novak, Frederik
    Nilsson, Anna Christine
    Nielsen, Christian
    Holm, Dorte K.
    ostergaard, Kamilla
    Bystrup, Anna
    Byg, Keld-Erik
    Johansen, Isik S.
    Mittl, Kristen
    Rowles, William
    Mcpolin, Kira
    Spencer, Collin
    Sagan, Sharon
    Gerungan, Chloe
    Wilson, Michael R.
    Zamvil, Scott S.
    Bove, Riley
    Sabatino, Joseph J.
    Sejbaek, Tobias
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 56
  • [35] Complement activation in circulation and central nervous system after Rituximab (Anti-CD20) treatment of B-Cell lymphoma
    Harjunpää, A
    Wiklund, T
    Collan, J
    Janes, R
    Rosenberg, J
    Lee, D
    Grillo-López, A
    Meri, S
    LEUKEMIA & LYMPHOMA, 2001, 42 (04) : 731 - 738
  • [36] Waning Humoral Immune Response to SARS-CoV-2 Vaccination with Symptomatic Infection after Initiation of Anti-CD20 Treatment in a Patient with Multiple Sclerosis
    Hoepner, Robert
    Salmen, Anke
    CLINICAL AND TRANSLATIONAL NEUROSCIENCE, 2022, 6 (01)
  • [37] Anti-CD20 therapy for older patients with B-cell non-Hodgkin lymphoma in the context of epidemic normalization
    Zhang, Dongdong
    Xu, Shuangnian
    ASIAN JOURNAL OF SURGERY, 2024, 47 (07) : 3290 - 3292
  • [38] Maintenance therapy using the anti-CD20 antibody Rituximab in patients with B-cell non-Hodgkin lymphoma
    Neumann, F
    Martin, S
    Kronenwett, R
    Fischer, C
    Kondakci, M
    Kobbe, G
    Gattermann, N
    Haas, R
    BLOOD, 2003, 102 (11) : 298B - 298B
  • [39] Prolonged SARS-CoV-2 shedding in a person living with advanced HIV and diffuse large B-cell lymphoma
    Maan, I.
    Paraskevopoulou, S.
    Cwynarski, K.
    Water, L.
    Miller, R.
    Ahmed, N.
    HIV MEDICINE, 2021, 22 : 58 - 58
  • [40] Pathogenic study of anti-CD20 infusion-related severe refractory shock in diffuse large B-cell lymphoma
    Gutiérrez, A
    Rodríguez, J
    Martínez, J
    Amezaga, R
    Ramos, R
    Galmes, B
    Bea, MD
    Ferrer, J
    Pons, J
    Sampol, A
    Morey, M
    Duran, MA
    Raurich, J
    Besalduch, J
    LEUKEMIA & LYMPHOMA, 2006, 47 (01) : 111 - 115
12345